Susquehanna International Group’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-18,300
Closed -$54.7K 14263
2022
Q4
$54.7K Hold
18,300
﹤0.01% 11340
2022
Q3
$55K Buy
+18,300
New +$45K ﹤0.01% 12142
2022
Q1
Sell
-10,700
Closed -$45K 14644
2021
Q4
$45K Sell
10,700
-32,300
-75% -$137K ﹤0.01% 12607
2021
Q3
$201K Sell
43,000
-71,800
-63% -$352K ﹤0.01% 11474
2021
Q2
$613K Buy
114,800
+104,700
+1,037% +$548K ﹤0.01% 9092
2021
Q1
$46K Hold
10,100
﹤0.01% 12054
2020
Q4
$37K Buy
+10,100
New +$38.8K ﹤0.01% 10815
2018
Q3
Sell
-11,200
Closed -$106K 10916
2018
Q2
$106K Sell
11,200
-28,400
-72% -$272K ﹤0.01% 9019
2018
Q1
$404K Buy
+39,600
New +$405K ﹤0.01% 7055

Other funds holding CO

Susquehanna International Group's CO Position: Q2 2023 in Review

Susquehanna International Group sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 13,333 shares — an estimated $39.8K sold.

Susquehanna International Group first reported a position in CO in Q2 2015 and held it in 20 quarters. The position peaked at $873K in Q2 2015. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.

  • Susquehanna International Group reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 13,333 Global Cord Blood Corporation shares in Q2 2023, an estimated $39.8K.
  • Susquehanna International Group first reported a position in Global Cord Blood Corporation in Q2 2015 and held it in 20 quarters.
  • Susquehanna International Group's Global Cord Blood Corporation position peaked at $873K in Q2 2015.
  • 6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.